Logo image of EVOK

EVOKE PHARMA INC (EVOK) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:EVOK - US30049G3020 - Common Stock

11 USD
+0.04 (+0.36%)
Last: 12/16/2025, 8:19:05 PM
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to EVOK. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 18.36. This target is 66.91% above the current price.
  • EVOK was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about EVOK.
  • In the last month the buy percentage fell by 40 points. So the trust of analysts is decreasing.
  • EVOK was analyzed by 6 analysts. More opinions would make the average more meaningful.
EVOK Historical Analyst RatingsEVOK Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -108 -98 -88 -78 -68 -58 -48 -38 -28 -18 -8 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 11.0018.1818.3618.3618.90 - 65.27% 66.91% 66.91% 71.82%
EVOK Current Analyst RatingEVOK Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

EVOKE PHARMA INC / EVOK FAQ

What do analysts expect the price target to be for EVOKE PHARMA INC (EVOK)?

6 analysts have analysed EVOK and the average price target is 18.36 USD. This implies a price increase of 66.91% is expected in the next year compared to the current price of 11.


How do analysts rate EVOKE PHARMA INC (EVOK)?

The consensus rating for EVOKE PHARMA INC (EVOK) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


How many analysts have analysed EVOKE PHARMA INC (EVOK)?

The number of analysts covering EVOKE PHARMA INC (EVOK) is 6.